Core Insights - The U.S. Food and Drug Administration has approved a new eye therapy from Glaukos Corp, providing patients with a less painful and more convenient treatment option for a progressive eye condition [1] Company Summary - Glaukos Corp has developed a new eye therapy that aims to improve patient comfort and convenience in treating a progressive eye condition [1] Industry Summary - The approval of this new therapy by the FDA highlights advancements in ophthalmic treatments, potentially impacting the market for eye care solutions [1]